Introduction & Objective: Identifying monogenic diabetes (MODY) remains a challenge for clinicians. Shields and colleagues developed a widely used MODY probability calculator (https://www.diabetesgenes.org/) based on clinical measures to assist in this decision. Because the calculator was developed in a predominantly adult White European population without any pediatric T2D cases, we sought to test its accuracy in ProDiGY, a multiethnic cohort with clinician-diagnosed T2D under age 20.

Methods: MODY calculator probabilities were computed for 615 youth with clinician-diagnosed T2D (n=147 in SEARCH, n=468 in TODAY; overall, >60% non-White), including 20 participants with MODY (3%). Given the longitudinal design of these studies, MODY probability was calculated for each participant at multiple time points, allowing maximum and median probabilities.

Results: Of the 20 individuals with MODY, 19 (95%) had a >60% median probability of having MODY. However, this calculator overestimated the probability in participants with no MODY variant detected. In fact, 85% of individuals without MODY had a maximum probability >60% of having MODY, and 67% had a median probability >60%. Family history of diabetes did not discriminate diabetes type with more T2D patients having a parent affected (64% v 55% in MODY). In contrast, HbA1c and BMI each had discriminatory capacity (ROC AUC >0.67).

Conclusion: In a group of multi-ethnic youth with diabetes, the MODY calculator correctly identified those with MODY but overestimated the probability for those with a clinical phenotype of T2D, likely due to young age at diagnosis and high proportion with positive family history of diabetes.

Disclosure

R.J. Kreienkamp: None. B. Shields: None. T.I. Pollin: None. M. Tosur: None. A.S. Shah: None. A.D. Liese: None. C. Pihoker: None. S. Srinivasan: None. A.T. Hattersley: None. M. Udler: Other Relationship; Up-To-Date. M.J. Redondo: None.

Funding

RJK is supported by NIH T32DK007699. SS is supported by NIH K23DK120932 and R03DK138213. MJR is supported by NIH NIDDK R01DK124395.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.